SARS-CoV-2 and Coronaviruses: Understanding Transmission, Impact, and Strategies for Prevention and Treatment DOI Creative Commons

Seyede Nafise Tabatabaei,

Zahra Keykhaee,

Saghi Nooraei

et al.

Drugs and Drug Candidates, Journal Year: 2025, Volume and Issue: 4(1), P. 5 - 5

Published: Feb. 10, 2025

COVID-19, first identified in December 2019 Wuhan, China, is caused by the SARS-CoV-2 virus, a pathogen that primarily targets respiratory system and can lead to severe conditions such as acute distress syndrome (ARDS). Among seven coronaviruses known infect humans, three—SARS-CoV, MERS-CoV, SARS-CoV-2—are associated with illness significant morbidity. an enveloped, single-stranded RNA virus utilizes angiotensin-converting enzyme 2 (ACE2) receptor for cellular entry. The genetic sequence of highly mutable, leading emergence variants alter disease pathology transmission dynamics. World Health Organization (WHO) has classified these mutations into concern (VOCs), interest (VOIs), under monitoring (VUMs). This review provides in-depth analysis both historical emerging variants, summarizes recent advancements diagnostic methods detection, discusses current therapeutic strategies particular focus on virus-like particle (VLP) vaccines developed years. Additionally, we highlight ongoing approaches their implications managing COVID-19.

Language: Английский

SARS-CoV-2 and Coronaviruses: Understanding Transmission, Impact, and Strategies for Prevention and Treatment DOI Creative Commons

Seyede Nafise Tabatabaei,

Zahra Keykhaee,

Saghi Nooraei

et al.

Drugs and Drug Candidates, Journal Year: 2025, Volume and Issue: 4(1), P. 5 - 5

Published: Feb. 10, 2025

COVID-19, first identified in December 2019 Wuhan, China, is caused by the SARS-CoV-2 virus, a pathogen that primarily targets respiratory system and can lead to severe conditions such as acute distress syndrome (ARDS). Among seven coronaviruses known infect humans, three—SARS-CoV, MERS-CoV, SARS-CoV-2—are associated with illness significant morbidity. an enveloped, single-stranded RNA virus utilizes angiotensin-converting enzyme 2 (ACE2) receptor for cellular entry. The genetic sequence of highly mutable, leading emergence variants alter disease pathology transmission dynamics. World Health Organization (WHO) has classified these mutations into concern (VOCs), interest (VOIs), under monitoring (VUMs). This review provides in-depth analysis both historical emerging variants, summarizes recent advancements diagnostic methods detection, discusses current therapeutic strategies particular focus on virus-like particle (VLP) vaccines developed years. Additionally, we highlight ongoing approaches their implications managing COVID-19.

Language: Английский

Citations

0